Multiple somatic symptoms predict impaired health status in functional somatic syndromes

International Journal of Behavioral Medicine

Volumn 20, Issue 2, 2013, Pages 194-205

  Creed, F H ^a   Tomenson, B ^a   Chew Graham, C ^a   MacFarlane, G J ^b   Davies, I ^a   Jackson, J ^a   Littlewood, A ^a   McBeth, J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Chronic fatigue; Chronic widespread pain; Functional somatic syndromes; Health status; Irritable bowel syndrome; Somatisation

Indexed keywords

ANXIETY; ARTICLE; CHRONIC FATIGUE SYNDROME; CHRONIC PAIN; DEPRESSION; FEMALE; HEALTH STATUS; HUMAN; IRRITABLE COLON; MALE; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; QUESTIONNAIRE; REGRESSION ANALYSIS; SOMATOFORM DISORDER; SYMPTOM ASSESSMENT; SYNDROME; UNITED KINGDOM; FATIGUE SYNDROME, CHRONIC; IRRITABLE BOWEL SYNDROME; PROCEDURES; SOMATOFORM DISORDERS;

ANXIETY; CHRONIC PAIN; DEPRESSION; FATIGUE SYNDROME, CHRONIC; FEMALE; GREAT BRITAIN; HEALTH STATUS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; REGRESSION ANALYSIS; SOMATOFORM DISORDERS; SYMPTOM ASSESSMENT; SYNDROME;

EID: 84877927218     PISSN: 10705503     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12529-012-9257-y     Document Type: Article

References (83)

1. Clark C, Goodwin L, Stansfeld SA, Hotopf M, White PD. Premorbid risk markers for chronic fatigue syndrome in the 1958 British birth cohort. Br J Psychiatry. 2011;199:323-9.
2. Clauw DJ, Arnold LM, McCarberg BH. The science of fibromyalgia. Mayo Clin Proc. 2011;86(9):907-11.
3. Sharpe M. Chronic fatigue syndrome: neurological, mental or both. J Psychosom Res. 2011;70(6):498-9.
4. Brandt LJ, Bjorkman D, Quigley E, et al. Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97(11 Suppl):S1-5.
5. Elsenbruch S. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun. 2011;25(3):386-94.
6. Wessely S, White PD. There is only one functional somatic syndrome. Br J Psychiatry. 2004;185:95-6.
7. Kato K, Sullivan P, Evengard B, Pedersen N. A population-based twin study of functional somatic syndromes. Psychol Med. 2009;39:487-505.
8. Kato K, Sullivan PF, Pedersen N. Latent class analysis of functional somatic symptoms in a population-based sample of twins. J Psychosom Res. 2010;68:447-53.
9. Knudsen AK, Henderson M, Harvey SB, Chalder T. Long-term sickness absence among patients with chronic fatigue syndrome. Br J Psychiatry. Sep 8. [Epub ahead of print]. 2011.
10. White PD. Chronic fatigue syndrome: is it one discrete syndrome or many? Implications for the one versus many functional somatic syndromes debate. J Psychosom Res. 2010;68:455-9.
11. Creed F, Fernandes L, Guthrie E, et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome [see comment]. Gastroenterology. 2003;124(2):303-17.
12. White P, Goldsmith K, Johnson A, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet. 2011;377(9768):823-36.
13. Creed FH, Kroenke K, Henningsen P, Gudi A, White P. Evidence-based treatment. In: Creed FH, Henningsen P, Fink P, editors. Medically unexplained symptoms, somatisation and bodily distress: developing better clinical services. Cambridge: Cambridge University Press; 2011.
14. Gupta A, Silman AJ, Ray D, et al. The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study. Rheumatology. 2007;46(4):666-71.
15. Creed FH, Barsky A, Leiknes KA. Epidemiology: prevalence, causes and consequences. Medically unexplained symptoms, somatisation and bodily distress: developing better clinical services. Cambridge: Cambridge University Press; 2011. p. 42.
16. Nicholl BI, Halder SL, Macfarlane GJ, et al. Psychosocial risk markers for new onset irritable bowel syndrome - results of a large prospective population-based study. Pain. 2008;137(1):147-55.
17. Hotopf M, Mayou R, Wadsworth M, et al. Temporal relationships between physical symptoms and psychiatric disorder. Results from a national birth cohort. Br J Psychiatry. 1998;173:255-61.
18. Kingma EM, de Jonge P, Ormel J, Rosmalen JGM. Predictors of a functional somatic syndrome diagnosis in patients with persistent functional somatic symptoms. Int J Behav Med 2012; in press.
19. Functional Somatic Syndromes. Etiology, diagnosis and treatment. Cambridge: Cambridge University Press; 1998.
20. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet. 2007;369(9565):946-55.
21. Geisser ME, Strader DC, Petzke F, et al. Comorbid somatic symptoms and functional status in patients with fibromyalgia and chronic fatigue syndrome: sensory amplification as a common mechanism. Psychosomatics. 2008;49(3):235-42.
22. Aaron LA, Bradley LA, Alarcon GS, et al. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum. 1996;39(3):436-45.
23. Spiegel BM, Kanwal F, Naliboff B, Mayer E. The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome. Am J Gastroenterol. 2005;100(10):2262-73.
24. Williams RE, Black CL, Kim HY, et al. Determinants of healthcare-seeking behaviour among subjects with irritable bowel syndrome. Aliment Pharmacol Ther. 2006;23(11):1667-75.
25. Creed F, Tomenson B, Guthrie E, et al. The relationship between somatisation and outcome in patients with severe irritable bowel syndrome. J Psychosom Res. 2008;64:613-20.
26. Palmer KT, Calnan M, Wainwright D, et al. Disabling musculoskeletal pain and its relation to somatization: a community-based postal survey. Occup Med (Oxford). 2005;55(8):612-7.
27. Aggarwal V, McBeth J, Zakrzewska JM, Lunt M, Macfarlane GJ. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors? Int J Epidemiol. 2006;35:468-76.
28. Koloski NA, Boyce PM, Talley NJ. Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study. Eur J Gastroenterol Hepatol. 2006;18(10):1101-9.
29. Locke GR, Weaver AL, Melton LJ, Talley NJ. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol. 2004;99(2):350-7.
30. Nicholl BI, Macfarlane GJ, Davies KA, Morriss R, Dickens C, McBeth J. Premorbid psychosocial factors are associated with poor health-related quality of life in subjects with new onset of chronic widespread pain - results from the EPIFUND study. Pain. 2009;141:119-26.
31. Hauser W, Schmutzer G, Brahler E, Glaesmer H. A cluster within the continuum of biopsychosocial distress can be labeled fibromyalgia syndrome - evidence from a representative German population survey. J Rheumatol. 2009;36(12):2806-12.
32. Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther. 2004;20(10):1195-203.
33. Johansson PA, Farup PG, Bracco A, Vandvik PO. How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice. BMC Gastroenterol. 2010;10:31.
34. Creed F, Ratcliffe J, Fernandez L, et al. Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med. 2001;134(9 Pt 2):860-8.
35. Creed FH. Somatization and pain syndromes. In: Mayer EA, Bushnell MC, editors. Functional chronic pain syndromes: presentation and pathophysiology. Seattle, WA: IASP Press; 2009. p. 227-44.
36. Creed FH, Davies I, Jackson J, et al. The epidemiology of multiple somatic symptoms. J Psychosom Res. 2012;72:311-7.
37. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-70.
38. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27(2):363-70.
39. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE. Research diagnostic questions for functional gastrointestinal disorders, Rome II modular questionnaire: investigator and respondent forms. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, editors. Rome II. The functional gastrointestinal disorders. Diagnosis, pathophysiology and treatment: a multinational consensus. McLean, VA: Degnon Associates; 2000. p. 669-88.
40. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res. 1993;37(2):147-53.
41. Cella M, Chalder T. Measuring fatigue in clinical and community settings. J Psychosom Res. 2010;69(1):17-22.
42. Derogatis LR, Lipman RS, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19:1-15.
43. Gandek B, Ware JE, Aaranson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1171-8.
44. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care. 1992;30(6):473-83.
45. Spiegel BM, Gralnek IM, Bolus R, et al. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch Intern Med. 2004;164(16):1773-80.
46. Hoffman DL, Dukes EM. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2008;62:115-26.
47. Ware JE, Kosinski M. Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220-33.
48. Williams A. Euroqol - A new facility for the measurement of Health-Related Quality-Of-Life. Health Policy. 1990;16(3):199-208.
49. Creed FH, Henningsen P, Byng R. Achieving optimal treatment organisation in different countries. Suggestions for service development applicable across different healthcare systems. In: Creed FH, Henningsen P, Fink P, editors. Medically unexplained symptoms, somatisation and bodily distress. Developing better clinical services. Cambridge: Cambridge University Press; 2011. p. 234-50.
50. Tomenson B, Essau C, Jacobi F et al. Total somatic symptom score is more closely correlated with outcome than medically unexplained symptoms. Submitted for publication, 2012.
51. Drossman DA. Rome III, The functional gastrointestinal disorders. 3rd ed. McLean, VA: Degnon Associates Inc.; 2006.
52. Lembo AJ, Zaman M, Krueger RF, Tomenson B, Creed FH. Psychiatric disorder, irritable bowel syndrome, and extra-intestinal symptoms in a population-based sample of twins. Am J Gastroenterol. 2009;104(3):686-94.
53. Nicholl BI, Holliday KL, Macfarlane GJ, et al. Association of HTR2A polymorphisms with chronic widespread pain and the extent of musculoskeletal pain. Arthritis Rheum. 2011;63(3):810-8.
54. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee [see comment]. Arthritis Rheum. 1990;33(2):160-72.
55. Martin A, Chalder T, Rief W, et al. The relationship between chronic fatigue and somatization syndrome: a general population survey. J Psychosom Res. 2007;63(2):147-56.
56. Hickie I, Lloyd A, Hadzipavlovic D, Parker G, Bird K, Wakefield D. Can the chronic fatigue syndrome be defined by distinct clinical-features. Psychol Med. 1995;25(5):925-35.
57. Jason LA, Corradi K, Torres-Harding S, Taylor RR, King C. Chronic fatigue syndrome: the need for subtypes. Neuropsychol Rev. 2005;15(1):29-58.
58. Mueller W, Schneider M, Joos T, Hsu H, Stratz T. Subgroups of fibromyalgia. Schmerz. 2007;21(5):424-9.
59. Giesecke T, Williams DA, Harris RE, et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum. 2003;48(10):2916-22.
60. Jackson J, Fiddler M, Kapur N, et al. Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics. J Psychosom Res. 2006;60(4):357-63.
61. Creed F. The relationship between somatic symptoms, health anxiety, and outcome in medical out-patients. Psychiatr Clin North Am. 2011;34(3):545-64.
62. Khoo EM, Mathers NJ, McCarthy SA, Low WY. Somatisation disorder and its associated factors in multiethnic primary care clinic attenders. Int J Behav Med 2011; May 12. [Epub ahead of print].
63. Duddu V, Husain N, Dickens C, Duddu V, Husain N, Dickens C. Medically unexplained presentations and quality of life: a study of a predominantly South Asian primary care population in England. J Psychosom Res. 2008;65(4):311-7.
64. Creed F, Guthrie E, Ratcliffe J, et al. Reported sexual abuse predicts impaired functioning but a good response to psychological treatments in patients with severe irritable bowel syndrome. Psychosom Med. 2005;67(3):490-9.
65. Fiddler M, Jackson J, Kapur N, et al. Childhood adversity and frequent medical consultations. Gen Hosp Psychiatr. 2004;26(5):367-77.
66. Filipkowski KB, Smyth JM, Rutchick AM, et al. Do healthy people worry? Modern health worries, subjective health complaints, perceived health, and health care utilization. Int J Behav Med. 2010;17(3):182-8.
67. Duddu V, Isaac MK, Chaturvedi SK, Duddu V, Isaac MK, Chaturvedi SK. Somatization, somatosensory amplification, attribution styles and illness behaviour: a review. Int Rev Psychiatr. 2006;18(1):25-33.
68. Köteles F, Simor P. Modern health worries, somatosensory amplification and subjective symptoms: a longitudinal study. Int J Behav Med 2011;Dec 30. [Epub ahead of print].
69. Van Oudenhove L, Vandenberghe J, Vos R, Holvoet L, Demyttenaere K, Tack J. Risk factors for impaired health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther. 2011;33(2):261-74.
70. Katon W, Lin EHB, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatr. 2007;29(2):147-55.
71. Fink P, Schroder A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res. 2010;68(5):415-26.
72. Dimsdale J, Creed FH. The proposed diagnosis of somatic symptom disorders in DSM-V to replace somatoform disorders in DSM-IV - a preliminary report. J Psychosom Res. 2009;66:473-6.
73. Rief W, Isaac M. Are somatoform disorders 'mental disorders'? A contribution to the current debate. Curr Opin Psychiatr. 2007;20:143-6.
74. Rief W, Rojas G, Rief W, Rojas G. Stability of somatoform symptoms - implications for classification. Psychosom Med. 2007;69(9):864-9.
75. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122(4):1140-56.
76. Moss-Morris R, Spence M, Moss-Morris R, Spence M. To lump or to split the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome? Psychosom Med. 2006;68(3):463-9.
77. Moss-Morris R, Spence M, Hou R. The pathway from glandular fever to chronic fatigue syndrome: can the cognitive behavioural model provide the map? Psychol Med. 2011;41(5):1099-107.
78. Spence MJ, Moss-Morris R, Spence MJ, Moss-Morris R. The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis [see comment]. Gut. 2007;56(8):1066-71.
79. Kato K, Sullivan PF, Evengard B, Pedersen NL. Chronic widespread pain and its comorbidities - A population-based study. Arch Intern Med. 2006;166(15):1649-54.
80. Kroenke K, Spitzer RL, deGruy III FV, et al. A symptom checklist to screen for somatoform disorders in primary care. Psychosomatics. 1998;39(3):263-72.
81. Hickie I, Davenport T, Vernon SD, et al. Are chronic fatigue and chronic fatigue syndrome valid clinical entities across countries and health-care settings? Aust New Zeal J Psychiatr. 2009;43(1):25-35.
82. Hickie I, Davenport T, Wakefield D, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333(7568):575.
83. Schumacher S, Rief W, Brähler E, Martin A, Glaesmer H, Mewes R. Disagreement in doctor's and patient's rating about medically unexplained symptoms and health care use. Int J Behav Med 2011;Dec 21. [Epub ahead of print].